journal article·2014-03Open access

Improving protein delivery of fibroblast growth factor-2 from bacterial inclusion bodies used as cell culture substrates

Joaquin Seras-Franzoso, Karl Peebo, Elena García-Fruitós, Esther Vázquez, Ursula Rinas, Antonio Villaverde

Acta Biomaterialia· Volume 10· Issue 3

Abstract

Bacterial inclusion bodies (IBs) have recently been used to generate biocompatible cell culture interfaces, with diverse effects on cultured cells such as cell adhesion enhancement, stimulation of cell growth or induction of mesenchymal stem cell differentiation. Additionally, novel applications of IBs as sustained protein delivery systems with potential applications in regenerative medicine have been successfully explored. In this scenario, with IBs gaining significance in the biomedical field, the fine tuning of this functional biomaterial is crucial. In this work, the effect of temperature on fibroblast growth factor-2 (FGF-2) IB production and performance has been evaluated. FGF-2 was overexpressed in Escherichia coli at 25 and 37 °C, producing IBs with differences in size, particle structure and biological activity. Cell culture topographies made with FGF-2 IBs biofabricated at 25 °C showed higher levels of biological activity as well as a looser supramolecular structure, enabling a higher protein release from the particles. In addition, the controlled use of FGF-2 protein particles enabled the generation of functional topographies with multiple biological activities being effective on diverse cell types.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Cancer Research and Treatments · Graphene and Nanomaterials Applications · Tissue Engineering and Regenerative Medicine

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (36)

Show source-provided references
1. Size and density of protein inclusion-bodies10.1038/nbt0686-553 ↗
2. The purification of eukaryotic polypeptides synthesized in Escherichia coli10.1042/bj2400001 ↗
3. Proteolytic digestion of bacterial inclusion body proteins during dynamic transition between soluble and insoluble forms10.1016/S0167-4838(99)00177-6 ↗
4. Dynamics of in vivo protein aggregation: building inclusion bodies in recombinant bacteria10.1016/S0378-1097(98)00444-3 ↗
5. The nanoscale properties of bacterial inclusion bodies and their effect on mammalian cell proliferation10.1016/j.biomaterials.2010.04.008 ↗
6. The chaperone DnaK controls the fractioning of functional protein between soluble and insoluble cell fractions in inclusion body-forming cells10.1186/1475-2859-5-26 ↗
7. Screening and identification of genetic loci involved in producing more/denser inclusion bodies in Escherichia coli10.1186/1475-2859-12-43 ↗
8. Engineering inclusion bodies for non denaturing extraction of functional proteins10.1186/1475-2859-7-34 ↗
9. Tunable geometry of bacterial inclusion bodies as substrate materials for tissue engineering10.1088/0957-4484/21/20/205101 ↗
10. Active inclusion bodies of acid phosphatase PhoC: aggregation induced by GFP fusion and activities modulated by linker flexibility10.1186/1475-2859-12-25 ↗
11. Fusion to a pull-down domain: a novel approach of producing Trigonopsis variabilisD-amino acid oxidase as insoluble enzyme aggregates10.1002/bit.21244 ↗
12. Physiological aggregation of maltodextrin phosphorylase from Pyrococcus furiosus and its application in a process of batch starch degradation to alpha-d-glucose-1-phosphate10.1007/s10295-007-0287-4 ↗
13. Biological role of bacterial inclusion bodies: a model for amyloid aggregation10.1111/j.1742-4658.2011.08165.x ↗
14. Using bacterial inclusion bodies to screen for amyloid aggregation inhibitors10.1186/1475-2859-11-55 ↗
15. Surface cell growth engineering assisted by a novel bacterial nanomaterial10.1002/adma.200900283 ↗
16. Bioadhesiveness and efficient mechanotransduction stimuli synergistically provided by bacterial inclusion bodies as scaffolds for tissue engineering10.2217/nnm.11.83 ↗
17. Topographically targeted osteogenesis of mesenchymal stem cells stimulated by inclusion bodies attached to polycaprolactone surfaces
18. Functional inclusion bodies produced in bacteria as naturally occurring nanopills for advanced cell therapies10.1002/adma.201104330 ↗
19. Inclusion bodies as potential vehicles for recombinant protein delivery into epithelial cells10.1186/1475-2859-11-67 ↗
20. Bacterial inclusion bodies as potential synthetic devices for pathogen recognition and a therapeutic substance release10.1186/1475-2859-12-16 ↗
21. Biological roles of fibroblast growth factor-2
22. Human basic fibroblast growth factor gene encodes four polypeptides: three initiate translation from non-AUG codons10.1073/pnas.86.11.3978 ↗
23. Nuclear activities of basic fibroblast growth factor: potentiation of low-serum growth mediated by natural or chimeric nuclear localization signals10.1091/mbc.10.5.1429 ↗
24. Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction10.1096/fasebj.9.10.7542215 ↗
25. A nanostructured bacterial bioscaffold for the sustained bottom-up delivery of protein drugs10.2217/nnm.12.188 ↗
26. Minimizing inclusion body formation during recombinant protein production in Escherichia coli at bench and pilot plant scale10.1016/j.enzmictec.2003.10.011 ↗
27. Aggregation as bacterial inclusion bodies does not imply inactivation of enzymes and fluorescent proteins10.1186/1475-2859-4-27 ↗
28. Production of nonclassical inclusion bodies from which correctly folded protein can be extracted10.1021/bp0497839 ↗
29. Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis10.1042/bj20031253 ↗
30. FGF-2 and VEGF functionalization of starPEG-heparin hydrogels to modulate biomolecular and physical cues of angiogenesis10.1016/j.biomaterials.2010.07.021 ↗
31. The effect of the controlled release of nerve growth factor from collagen gel on the efficiency of neural cell culture10.1016/j.biomaterials.2008.09.021 ↗
32. The effect of an rhBMP-2 absorbable collagen sponge-targeted system on bone formation in vivo10.1016/j.biomaterials.2008.12.046 ↗
33. Carrier-free immobilized enzymes for biocatalysis10.1007/s10529-009-0173-4 ↗
34. New properties of inclusion bodies with implications for biotechnology10.1042/BA20070140 ↗
35. Divergent genetic control of protein solubility and conformational quality in Escherichia coli10.1016/j.jmb.2007.09.004 ↗
36. Packaging protein drugs as bacterial inclusion bodies for therapeutic applications10.1186/1475-2859-11-76 ↗